Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.2840
-0.0177 (-5.87%)
At close: Jul 2, 2026, 4:00 PM EDT
0.2913
+0.0073 (2.57%)
After-hours: Jul 2, 2026, 7:59 PM EDT
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $4.17 million as of July 2, 2026. Its market cap has decreased by -15.37% in one year.
Market Cap
4.17M
Enterprise Value
3.67M
1-Year Change
-15.37%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since February 26, 2018, Ensysce Biosciences's market cap has decreased from $59.64B to $4.17M, a decrease of -99.99%. That is a compound annual growth rate of -68.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 4.17M | 24.88% |
| Dec 31, 2025 | 3.34M | -68.54% |
| Dec 31, 2024 | 10.62M | 218.52% |
| Dec 29, 2023 | 3.33M | -30.67% |
| Dec 30, 2022 | 4.81M | -95.78% |
| Dec 31, 2021 | 113.99M | -99.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evogene | 4.56M |
| 60 Degrees Pharmaceuticals | 4.55M |
| Creative Medical Technology Holdings | 4.47M |
| Alzamend Neuro | 4.41M |
| Revelation Biosciences | 4.22M |
| GeoVax Labs | 4.13M |
| Matinas BioPharma Holdings | 4.06M |
| Propanc Biopharma | 4.03M |